A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection

SARS-CoV-2 has mutated frequently since its first emergence in 2019. Numerous variants, including the currently emerging Omicron variant, have demonstrated high transmissibility or increased disease severity, posing serious threats to global public health. This study describes the identification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Juan, Zheng, Jian, Tai, Wanbo, Verma, Abhishek K., Zhang, Xiujuan, Geng, Qibin, Wang, Gang, Guan, Xiaoqing, Malisheni, Moffat M., Odle, Abby E., Zhang, Wei, Li, Fang, Perlman, Stanley, Du, Lanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472618/
https://www.ncbi.nlm.nih.gov/pubmed/35972290
http://dx.doi.org/10.1128/jvi.00118-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472618/
https://www.ncbi.nlm.nih.gov/pubmed/35972290
http://dx.doi.org/10.1128/jvi.00118-22

Ejemplares similares